Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

Genital psoriasis affects 3-33% of patients with psoriasis during the course of the disease, usually leading to a severe reduction in the patient’s quality of life. This study aims to retrospectively assess the effectiveness of interleukin (IL)-23 and IL-17 inhibitors in a real-life population affec...

Descripción completa

Detalles Bibliográficos
Autores principales: Cortese, Andrea, Gargiulo, Luigi, Ibba, Luciano, Fiorillo, Giovanni, Toso, Francesco, Vignoli, Carlo Alberto, Narcisi, Alessandra, Costanzo, Antonio, Valenti, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543193/
https://www.ncbi.nlm.nih.gov/pubmed/37790655
http://dx.doi.org/10.4081/dr.2023.9692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543193/
https://www.ncbi.nlm.nih.gov/pubmed/37790655
http://dx.doi.org/10.4081/dr.2023.9692

Ejemplares similares